ZWJ Investment Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History

ZWJ Investment Counsel’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	2,198 +42	+2%	+$18.6K	0.04%	126
2026 Q1	$963K	Sell	2,156 -831	-28%	-$387K	0.03%	123
2025 Q4	$1.35M	Sell	2,987 -804	-21%	-$347K	0.05%	106
2025 Q3	$1.48M	Buy	3,791 +14	+0.4%	+$5.85K	0.05%	105
2025 Q2	$1.68M	Buy	3,777 +13	+0.3%	+$5.99K	0.06%	97
2025 Q1	$1.82M	Buy	3,764 +2,100	+126%	+$979K	0.07%	99
2024 Q4	$670K	Buy	1,664 +4	+0.2%	+$1.85K	0.03%	128
2024 Q3	$772K	Hold	1,660	–	–	0.03%	124
2024 Q2	$778K	Sell	1,660 -35	-2%	-$15.2K	0.03%	122
2024 Q1	$709K	Buy	1,695 +1,109	+189%	+$469K	0.03%	125
2023 Q4	$238K	Hold	586	–	–	0.01%	179
2023 Q3	$204K	Buy	+586	New	+$205K	0.01%	186
2020 Q2	–	Sell	-1,870	Closed	-$445K	–	194
2020 Q1	$445K	Hold	1,870	–	–	0.04%	140
2019 Q4	$409K	Buy	+1,870	New	+$378K	0.03%	163

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ZWJ Investment Counsel's VRTX Position: Q2 2026 in Review

ZWJ Investment Counsel increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, buying an estimated $18.6K and bringing the position to 2,198 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #126.

ZWJ Investment Counsel first reported a position in VRTX in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.82M in Q1 2025. 677 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

ZWJ Investment Counsel held 2,198 shares of Vertex Pharmaceuticals worth $1.09M as of Q2 2026.
ZWJ Investment Counsel bought 42 Vertex Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
Vertex Pharmaceuticals made up 0.04% of ZWJ Investment Counsel's portfolio in Q2 2026, its #126 holding.
ZWJ Investment Counsel first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
ZWJ Investment Counsel's Vertex Pharmaceuticals position peaked at $1.82M in Q1 2025.
677 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on ZWJ Investment Counsel's 13F filing for Q2 2026, filed 16 Jul 2026.